Síntesis de nanopartículas de cobre y oligómeros de quitosano y estudio in vitro de su acción fungicida frente a Trametes versicolor aislado y en madera de Populus sp.

El presente TFM aborda la síntesis de compuestos basados en nanopartículas de cobre y oligómeros de quitosano con el fin de evaluarlos frente al hongo de pudrición blanca de la madera Trametes versicolor. Se han realizado dos ensayos: el primero siguiendo el método de dilución en agar y el segundo mediante un tratamiento de inmersión de probetas de madera de Populus sp. Los resultados indican actividad antifúngica por parte de todos los compuestos evaluados.Máster en Ingeniería de Montes2018-06-3

Plan de defensa contra grandes incendios forestales en el norte de la comarca de Las Merindades (Burgos)

Plan de defensa contra incendios forestales, que tiene como condicionantes principales las características particulares de una zona concreta de la geografía de Castilla y León: los ocho municipios de la zona noroeste de la comarca de “Las Merindades” (provincia de Burgos).Grado en Ingeniería Forestal y del Medio Natura

Effects of Fatigue Induced by Repetitive Movements and Isometric Tasks on Reaction Time

[Abstract] Purpose: The understanding of fatigue of the human motor system is important in the fields of ergonomics, sport, rehabilitation and neurology. In order to understand the interactions between fatigue and reaction time, we evaluated the effects of two different fatiguing tasks on reaction time. Methods: 83 healthy subjects were included in a case-control study with three arms where single and double choice reaction time tasks were performed before and after 2 min fatiguing task (an isometric task, a finger tapping task and at rest). Results: After an isometric task, the right-fatigued hand was slower in the choice component of a double choice reaction time task (calculated as the individual difference between single and double choice reaction times); also, the subjects that felt more fatigued had slower choice reaction time respect to the baseline assessment. Moreover, in relationship to the performance decay after two minutes, finger tapping task produces more intense fatigability perception. Conclusions: We confirmed that two minutes of isometric or repetitive tasks are enough to produce fatigue. The fatigue perception is more intense for finger tapping tasks in relation to the performance decay. We therefore confirmed that the two fatiguing tasks produced two different kind of fatigue demonstrating that with a very simple protocol it is possible to test subjects or patients to quantify different form of fatigue.Ministerio de Economía y Competitividad; SAF2016-80647-

Local wind speed forecasting based on WRF-HDWind coupling

[EN] Wind speed forecasts obtained by Numerical Weather Prediction models are limited for fine interpretation in heterogeneous terrain, in which different roughnesses and orographies occur. This limitation is derived from the use of low-resolution and grid-box averaged data. In this paper a dynamical downscaling method is presented to increase the local accuracy of wind speed forecasts. The proposed method divides the wind speed forecasting into two steps. In the first one, the mesoscale model WRF (Weather Research and Forecasting) is used for getting wind speed forecasts at specific points of the study domain. On a second stage, these values are used for feeding the HDWind microscale model. HDWind is a local model that provides both a high-resolution wind field that covers the entire study domain and values of wind speed and direction at very located points. As an example of use of the proposed method, we calculate a high-resolution wind field in an urban-interface area from Badajoz, a South-West Spanish city located near the Portugal border. The results obtained are compared with the values read by a weathervane tower of the Spanish State Meteorological Agency (AEMET) in order to prove that the microscale model improves the forecasts obtained by the mesoscale model

Eastern boundary drainage of the North Atlantic subtropical gyre

24 pages, 17 figures, 4 tablesThe eastern boundary of the North Atlantic subtropical gyre (NASG) is an upwelling favorable region characterized by a mean southward flow. The Canary Upwelling Current (CUC) feeds from the interior ocean and flows south along the continental slope off NW Africa, effectively providing the eastern boundary condition for the NASG. We follow a joint approach using slope and deep-ocean data together with process-oriented modeling to investigate the characteristics and seasonal variability of the interior-coastal ocean connection, focusing on how much NASG interior water drains along the continental slope. First, the compiled sets of data show that interior central waters flow permanently between Madeira and the Iberian Peninsula at a rate of 2.5±0.6 Sv (1 Sv = 106 m3 s-1 109 km s-1), with most of it reaching the slope and shelf regions north of the Canary Islands (1.5±0.7 Sv). Most of the water entering the African slope and shelf regions escapes south between the easternmost Canary Islands and the African coast: In 18 out of 22 monthly realizations, the flow was southward (-0.9±0.4 Sv) although an intense flow reversal occurred usually around November (1.7±0.9 Sv), probably as the result of a late fall intensification of the CUC north of the Canary Islands followed by instability and offshore flow diversion. Secondly, we explore how the eastern boundary drainage may be specified in a process-oriented one-layer quasigeostrophic numerical model. Non-zero normal flow and constant potential vorticity are alternative eastern boundary conditions, consistent with the idea of anticyclonic vorticity induced at the boundary by coastal jets. These boundary conditions cause interior water to exit the domain at the boundary, as if recirculating through the coastal ocean, and induce substantial modifications to the shape of the eastern NASG. The best model estimate for the annual mean eastward flow north of Madeira is 3.9 Sv and at the boundary is 3.3 Sv. The water exiting at the boundary splits with 1 Sv flowing into the Strait of Gibraltar and the remaining 2.3 Sv continuing south along the coastal ocean until the latitude of Cape Ghir. The model also displays significant wind-induced seasonal variability, with a maximum connection between the interior and coastal oceans taking place in autumn and winter, in qualitative agreement with the observationsThis work has been supported by the European Union through the CANIGO project (MAS3-CT96-0060) and by the Ministerio de Ciencia e Innovación of the Spanish Government through projects CANOA (CTM2005-00444) and MOC2-Ecuatorial (CTM2008-06438-C02-01/MAR). Dr. Laiz was partially supported by the Spanish Ministerio de Ciencia e Innovación through the “Juan de la Cierva Programme” and through project “CLI-CGL2008-04736.”Peer Reviewe

PhyFire: An Online GIS-Integrated Wildfire Spread Simulation Tool Based on a Semiphysical Model

[EN]The PhyFire simplified physical wildfire spread model developed by the research group on Numerical Simulation and Scientific Computation at the University of Salamanca has been integrated into an online GIS interface in order to facilitate its use, automate the data input process, thereby reducing error and improving efficiency, and upgrade the graphical display of simulation results. The main features of the PhyFire model are presented: model equations, numerical solution and GIS integration. A description is provided of new advances in the PhyFire model related to the addition of random phenomena, such as fire-spotting. A real wildfire simulation with fire-spotting is also presented

Osteoporosis, densidad mineral ósea y complejo CKD-MBD (I): consideraciones diagnósticas

Resumen: Osteoporosis (OP) y enfermedad renal crónica (ERC) influyen de manera independiente en la salud ósea y cardiovascular. Un número significativo de pacientes con ERC, especialmente desde estadios 3a a 5D, presentan una disminución significativa de la densidad mineral ósea condicionando un alto riesgo de fractura y un incremento importante de la morbimortalidad asociada. Independientemente de la OP clásica asociada a edad y/o sexo, las propiedades mecánicas del hueso se encuentran afectadas adicionalmente por factores intrínsecos a la ERC («OP urémica»). En la primera parte de esta revisión, analizaremos conceptos generales sobre densidad mineral ósea, OP y fracturas, en gran parte infravalorados hasta ahora por los nefrólogos debido a la falta de evidencias y a las dificultades diagnósticas en el contexto de la ERC. Actualmente se ha demostrado que una densidad mineral ósea disminuida es realmente predictiva del riesgo de fracturas en pacientes con ERC, aunque no permite distinguir entre las causas que la originan (hiperparatiroidismo, enfermedad adinámica del hueso y/o osteoporosis senil, etc.). Por ello, en la segunda parte analizaremos las implicaciones terapéuticas en distintos estadios de la ERC. En cualquier caso, la valoración individualizada de los factores mayores y menores del riesgo de fractura, la cuantificación de dicho riesgo (i.e. con el uso de herramientas como el FRAX®) y las indicaciones potenciales de densitometría en pacientes con ERC podrían constituir un primer paso importante en espera de nuevas guías clínicas basadas en estudios aleatorizados que no excluyan a pacientes con ERC, evitando mientras tanto nihilismo terapéutico en un área de creciente importancia. Abstract: Osteoporosis (OP) and chronic kidney disease (CKD) independently influence bone and cardiovascular health. A considerable number of patients with CKD, especially those with stages 3a to 5D, have a significantly reduced bone mineral density leading to a high risk of fracture and a significant increase in associated morbidity and mortality. Independently of classic OP related to age and/or gender, the mechanical properties of bone are also affected by inherent risk factors for CKD (“uraemic OP”). In the first part of this review, we will analyse the general concepts regarding bone mineral density, OP and fractures, which have been largely undervalued until now by nephrologists due to the lack of evidence and diagnostic difficulties in the context of CKD. It has now been proven that a reduced bone mineral density is highly predictive of fracture risk in CKD patients, although it does not allow a distinction to be made between the causes which generate it (hyperparathyroidism, adynamic bone disease and/or senile osteoporosis, etc.). Therefore, in the second part, we will analyse the therapeutic indications in different CKD stages. In any case, the individual assessment of factors which represent a higher or lower risk of fracture, the quantification of this risk (i.e. using tools such as FRAX®) and the potential indications for densitometry in patients with CKD could represent an important first step pending new clinical guidelines based on randomised studies which do not exclude CKD patients, all the while avoiding therapeutic nihilism in an area of growing importance. Palabras clave: Osteoporosis, CKD-MBD, Densidad mineral ósea, Fracturas, FRAX, Enfermedad renal crónica, DEXA, Keywords: Osteoporosis, CKD-MBD, Bone mineral density, Fractures, FRAX, Chronic kidney disease, DEX

Osteoporosis, bone mineral density and CKD–MBD complex (I): Diagnostic considerations

Osteoporosis (OP) and chronic kidney disease (CKD) independently influence bone and cardiovascular health. A considerable number of patients with CKD, especially those with stages 3a to 5D, have a significantly reduced bone mineral density leading to a high risk of fracture and a significant increase in associated morbidity and mortality. Independently of classic OP related to age and/or gender, the mechanical properties of bone are also affected by inherent risk factors for CKD (“uraemic OP”). In the first part of this review, we will analyse the general concepts regarding bone mineral density, OP and fractures, which have been largely undervalued until now by nephrologists due to the lack of evidence and diagnostic difficulties in the context of CKD. It has now been proven that a reduced bone mineral density is highly predictive of fracture risk in CKD patients, although it does not allow a distinction to be made between the causes which generate it (hyperparathyroidism, adynamic bone disease and/or senile osteoporosis, etc.). Therefore, in the second part, we will analyse the therapeutic indications in different CKD stages. In any case, the individual assessment of factors which represent a higher or lower risk of fracture, the quantification of this risk (i.e. using tools such as FRAX®) and the potential indications for densitometry in patients with CKD could represent an important first step pending new clinical guidelines based on randomised studies which do not exclude CKD patients, all the while avoiding therapeutic nihilism in an area of growing importance. Resumen: Osteoporosis (OP) y enfermedad renal crónica (ERC) influyen de manera independiente en la salud ósea y cardiovascular. Un número significativo de pacientes con ERC, especialmente desde estadios 3a a 5D, presentan una disminución significativa de la densidad mineral ósea condicionando un alto riesgo de fractura y un incremento importante de la morbimortalidad asociada. Independientemente de la OP clásica asociada a edad y/o sexo, las propiedades mecánicas del hueso se encuentran afectadas adicionalmente por factores intrínsecos a la ERC («OP urémica»). En la primera parte de esta revisión, analizaremos conceptos generales sobre densidad mineral ósea, OP y fracturas, en gran parte infravalorados hasta ahora por los nefrólogos debido a la falta de evidencias y a las dificultades diagnósticas en el contexto de la ERC. Actualmente se ha demostrado que una densidad mineral ósea disminuida es realmente predictiva del riesgo de fracturas en pacientes con ERC, aunque no permite distinguir entre las causas que la originan (hiperparatiroidismo, enfermedad adinámica del hueso y/o osteoporosis senil, etc.). Por ello, en la segunda parte analizaremos las implicaciones terapéuticas en distintos estadios de la ERC. En cualquier caso, la valoración individualizada de los factores mayores y menores del riesgo de fractura, la cuantificación de dicho riesgo (i.e. con el uso de herramientas como el FRAX®) y las indicaciones potenciales de densitometría en pacientes con ERC podrían constituir un primer paso importante en espera de nuevas guías clínicas basadas en estudios aleatorizados que no excluyan a pacientes con ERC, evitando mientras tanto nihilismo terapéutico en un área de creciente importancia. Keywords: Osteoporosis, CKD–MBD, Bone mineral density, Fractures, FRAX, Chronic kidney disease, DEXA, Palabras clave: Osteoporosis, CKD-MBD, Densidad mineral ósea, Fracturas, FRAX, Enfermedad renal crónica, DEX

Osteoporosis, densidad mineral ósea y complejo CKD-MBD (II): implicaciones terapéuticas

Resumen: La osteoporosis (OP) y la enfermedad renal crónica (ERC) influyen independientemente en la salud ósea. Numerosos pacientes con ERC presentan una disminución de densidad mineral ósea (DMO), un elevado riesgo de fracturas por fragilidad ósea y un incremento de su morbimortalidad. Con el envejecimiento de la población estos hechos no son dependientes solo de la «osteodistrofia renal» sino también de la OP asociada. Dado que la DMO tiene capacidad predictiva en pacientes con ERC (parte I), ahora analizaremos las implicaciones terapéuticas derivadas. Análisis post hoc de estudios aleatorizados han mostrado que fármacos como alendronato, risedronato, raloxifeno, teriparatida o denosumab tienen una eficacia comparable a la población general en pacientes con una disminución leve-moderada del filtrado glomerular (especialmente ERC-3). Estos estudios tienen limitaciones, pues incluyen mayoritariamente mujeres «sanas», sin diagnóstico conocido de ERC y habitualmente con parámetros normales de laboratorio; sin embargo, también existen datos positivos preliminares en estadios más avanzados (ERC-4) y más limitados en ERC-5D. Por todo ello, al menos en ausencia de alteraciones significativas del metabolismo mineral (i.e., hiperparatiroidismo severo), el beneficio potencial de dichos fármacos debería ser considerado en pacientes que presenten un riesgo de fractura elevado o muy elevado. Es novedad importante que las nuevas guías no condicionan su uso a la práctica de una biopsia ósea previa y que el beneficio/riesgo de estos fármacos podría estar justificado. Sin embargo, debemos considerar que la mayoría de estudios no son consistentes y tienen un bajo grado de evidencia, por lo que la indicación farmacológica (riesgo/beneficio) debe ser individualizada y prudente. Abstract: Osteoporosis (OP) and chronic kidney disease (CKD) both independently affect bone health. A significant number of patients with CKD have decreased bone mineral density (BMD), are at high risk of fragility fractures and have an increased morbidity and mortality risk. With an ageing population, these observations are not only dependent on “renal osteodystrophy” but also on the associated OP. As BMD predicts incident fractures in CKD patients (part I), we now aim to analyse the potential therapeutic consequences. Post-hoc analyses of randomised studies have shown that the efficacy of drugs such as alendronate, risedronate, raloxifene, teriparatide and denosumab is similar to that of the general population in patients with a mild/moderate decline in their glomerular filtration rate (especially CKD-3). These studies have some flaws however, as they included mostly “healthy” women with no known diagnosis of CKD and generally with normal lab test results. Nevertheless, there are also some positive preliminary data in more advanced stages (CKD-4), even though in CKD-5D they are more limited. Therefore, at least in the absence of significant mineral metabolism disorders (i.e. severe hyperparathyroidism), the potential benefit of these drugs should be considered in patients with a high or very high fracture risk. It is an important change that the new guidelines do not make it a requirement to first perform a bone biopsy and that the risk/benefit ratio of these drugs may be justified. However, we must also be aware that most studies are not consistent and the level of evidence is low. Consequently, any pharmacological intervention (risk/benefit) should be prudent and individualised. Palabras clave: Osteoporosis, CKD-MBD, Densidad mineral ósea, Fracturas, ERC, DEXA, Bisfosfonatos, Denosumab, Romosozumab, Keywords: Osteoporosis, CKD-MBD, Bone mineral density, Fractures, CKD, DEXA, Bisphosphonates, Denosumab, Romosozuma